Clinical Trial: Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT06896994) titled 'Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia' on March 19.

Brief Summary: To assess the 1-week effects and safety of esketamine in combination with pregabalin and duloxetine to relieve pain in patients with postherpetic Neuralgia(PHN).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Postherpetic Neuralgia

Intervention: DRUG: esketamine group

In the esketamine group, in addition to receiving the combination of pregabalin and duloxetine, patients will also undergo a single intravenous infusion of esketamine.

DRUG: control group

receiving the combination of pregabalin and duloxetin...